Published in AIDS on July 11, 2007
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis (2010) 1.36
Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis (2011) 1.22
Discovery and genomic characterization of a novel ovine partetravirus and a new genotype of bovine partetravirus. PLoS One (2011) 1.10
Parvovirus 4-like virus in blood products. Emerg Infect Dis (2010) 1.08
High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis (2011) 1.05
Parvoviruses in blood donors and transplant patients, Italy. Emerg Infect Dis (2008) 1.05
Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan. Emerg Infect Dis (2011) 1.04
Human parvovirus 4 in kidney transplant patients, France. Emerg Infect Dis (2008) 1.00
Parvovirus 4 in blood donors, France. Emerg Infect Dis (2010) 1.00
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J (2010) 0.95
Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology (2011) 0.95
Human parvovirus 4 infection, Cameroon. Emerg Infect Dis (2012) 0.87
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? Transfusion (2012) 0.78
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus (2015) 0.76
No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults. PLoS One (2012) 0.76
Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med (2006) 2.30
Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science (2002) 1.97
A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol (2008) 1.74
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. J Infect Dis (2002) 1.52
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother (2009) 1.40
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS (2006) 1.40
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin. AIDS (2002) 1.37
Leishmaniasis among organ transplant recipients. Lancet Infect Dis (2008) 1.29
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS (2010) 1.26
Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis (2002) 1.17
Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children. Pediatrics (2002) 1.17
Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) (2006) 1.15
Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol (2009) 1.03
Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia. Am J Hematol (2006) 1.03
Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect (2012) 1.02
The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol (2005) 1.01
Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. J Travel Med (2005) 1.00
Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis (2001) 1.00
Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years. Int J Infect Dis (2012) 0.98
Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis (2008) 0.97
What is new in esophageal injury (infection, drug-induced, caustic, stricture, perforation)? Curr Opin Gastroenterol (2009) 0.93
Radiculoneuropathy associated with acute hepatitis E. Dig Liver Dis (2013) 0.92
Disseminated microsporidiosis caused by Encephalitozoon cuniculi III (dog type) in an Italian AIDS patient: a retrospective study. Mod Pathol (2002) 0.92
Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults. Curr HIV Res (2010) 0.90
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clin Infect Dis (2004) 0.90
Plasmodium knowlesi: the emerging zoonotic malaria parasite. Acta Trop (2012) 0.90
Intestinal lymphangiectasia and reversible high liver stiffness. Hepatology (2014) 0.89
Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria. Clin Infect Dis (2002) 0.89
HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. AIDS (2003) 0.88
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. J Antimicrob Chemother (2010) 0.88
Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res (2011) 0.88
Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART. J Acquir Immune Defic Syndr (2013) 0.87
Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature. AIDS Patient Care STDS (2010) 0.86
Is real-time polymerase chain reaction (PCR) more useful than a conventional PCR for the clinical management of leishmaniasis? Am J Trop Med Hyg (2009) 0.86
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics. AIDS (2004) 0.86
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study. Curr HIV Res (2010) 0.85
Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. AIDS Res Hum Retroviruses (2012) 0.85
Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy. Eur J Ophthalmol (2014) 0.85
ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP. Thromb Haemost (2003) 0.85
Safety of statin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr (2007) 0.85
[13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother (2004) 0.85
Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors. J Infect Dis (2002) 0.84
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N Engl J Med (2012) 0.84
A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy. Antivir Ther (2013) 0.83
Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapy. PLoS One (2010) 0.83
A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience. J Antimicrob Chemother (2004) 0.82
What is new in esophageal injury (infection, drug-induced, caustic, stricture, perforation)? Curr Opin Gastroenterol (2009) 0.82
Severe Plasmodium vivax malaria: fact or fiction? Clin Infect Dis (2012) 0.82
Successful rescue therapy with a darunavir/ritonavir and etravirine antiretroviral regimen in a child with vertically acquired multidrug-resistant HIV-1. Antivir Ther (2008) 0.82
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART. AIDS (2010) 0.82
Biology of human malaria plasmodia including Plasmodium knowlesi. Mediterr J Hematol Infect Dis (2012) 0.82
Thrombocytopenia and Plasmodium vivax malaria. Clin Infect Dis (2005) 0.81
Risks of dental amalgam in children. JAMA (2006) 0.81
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.81
Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy. Clin Infect Dis (2002) 0.81
Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study. AIDS Res Hum Retroviruses (2010) 0.80
Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy. Clin Infect Dis (2008) 0.80
Diagnosis and therapy for hospitalized imported malaria in adults in Italy. J Travel Med (2011) 0.80
Usefulness of serial determination of Aspergillus galactomannan in the diagnosis and management of invasive aspergillosis in an AIDS patient with non-Hodgkin lymphoma. Mycoses (2011) 0.80
Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients. J Acquir Immune Defic Syndr (2007) 0.79
A rare case of localized mucosal leishmaniasis due to Leishmania infantum in an immunocompetent Italian host. Eur J Epidemiol (2005) 0.79
Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy. BMC Infect Dis (2013) 0.79
Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting. AIDS (2003) 0.78
Nongastroesophageal reflux disease-related infectious, inflammatory and injurious disorders of the esophagus. Curr Opin Gastroenterol (2007) 0.78
Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report. Antivir Ther (2005) 0.78
Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014. Mycopathologia (2014) 0.78